New Delhi: The Serum Institute of India (SII), manufacturer of the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer Adar Poonawalla, told The Times, said an NDTV report.
“There’s going to be an announcement in the next few days,” he was quoted as saying by the newspaper in an interview published on Friday.
Earlier last week, he had said that SII would be able to raise its monthly output to 100 million doses by July, as opposed to the previous timeline of May end.
He hoped to increase the Serum Institute’s production capacity from 2.5 billion to 3 billion doses a year within six months, the Times reported, adding that he flew to London before Britain banned travellers from India eight days ago.
Bhubaneswar: Odisha Chief Minister on Tuesday issued direction to provide rice of three months' quota…
Mumbai: In the wake of a fresh death threat by the Lawrence Bishnoi gang, actor…
Mumbai: Rumours about Abhishek Bachchan and Aishwarya Rai’s divorce have been doing the rounds for…
New Delhi: Hospitals across Delhi are witnessing a spike in the number of patients with…
Bhubaneswar: Facing a strong opposition from the devotees of Lord Jagannath and Puri Gajapati Maharaja…
Mumbai: The trailer of the highly-anticipated Abhishek Bachchan starrer ‘I Want to Talk’ was unveiled…
Berhampur: One person was killed and two others were injured in a collision between a…
Mumbai: Bollywood actress Raveena Tandon’s beautiful daughter Rasha Thadani is all set to make her…